SIGNALS MEMBERSHIP
The kidney health ecosystem for those shaping what comes next.
A network of clinicians, industry leaders, operators, advocates, and policymakers, with exclusive access to briefs, private discussions, original research, and a member directory.
Member benefits
What membership includes.
Member-only sessions
A private briefing every other month on kidney care policy, value-based care models, scientific advances, market trends, and the innovation pipeline. Join live discussions with peers and featured voices from across the field.
Discounted research access
Members pay 20% less on all research products. The library includes the annual Kidney VBC Report and individual research briefs, with a strategy session option for teams that want to apply the findings to their business.
View research products →Member directory
A searchable directory of Signals members across practices, health plans, biopharma, research, and advocacy. Find and connect with the right people in the ecosystem.
Join the conversation on Slack.
The #general Slack channel is open to everyone. Members get access to private channels for making connections, requesting intros, and staying up to date on the CKM space, with the Signals team actively in the loop.
Free Slack members are always welcome to upgrade to a paid membership tier to unlock access to #asks and #intros.
Who this is designed for
Built for the people doing the work, across care, ops, discovery, and access.
Nephrologists & kidney specialists
Clinicians shaping the standard of care.
Health plan & payer executives
Leaders designing coverage, networks, and value-based models.
Biopharma & medtech professionals
Teams developing the next generation of therapies and devices.
Researchers & academics
Investigators advancing the underlying science.
Patient advocates
People with lived experience guiding the field.
Founders building in the space
Operators starting companies in kidney and cardiometabolic care.
Who belongs in the room
One member experience, tiered by organizational capacity.
| Member type | Who this is for | Annual dues |
|---|---|---|
Founding partner | By invitation only, limited to 5 organizations | $25,000 |
Large organization | 500+ employees or revenues >$1 billion | $10,000 |
Mid-size organization | 50-500 employees or revenues $50M to $1B | $5,000 |
Small organization | Up to 50 employees or revenues $5M to $50M | $2,500 |
Startup | Less than $3M raised | $1,000 |
Non-profit organization | Foundations, societies, and advocacy groups | $500 |
IndividualJoin today | Clinicians, executives, and operators joining personally | $150* |
Government agency | Federal, state, and international public health bodies | Free |
Patient / patient advocate | People living with kidney disease and their advocates | Free |
Where the people building the future of kidney care come to learn, connect, and move forward.
Get started here
Ready to join?
Individuals can join directly. Organizations go through a short intake so we can confirm the right tier and get you and your team set up.
FOR INDIVIDUALS
Founding rate through Dec 31 · $250 after
Clinicians, researchers, and operators joining personally. Access is live as soon as payment clears.
Instant access · Cancel anytime
FOR ORGANIZATIONS
Health systems, payers, pharma, medtech, research, and advocacy groups.
SEE TIERS ↑- Tier confirmed within one business day
- Invoiced billing, no card required
- Multi-seat access for your team
Founding members
The inaugural cohort that shaped this community.
Founding members joined Signals before we opened publicly and helped define how we operate. That includes the cadence of the brief, the norms of the Slack, and the bar for who gets invited next. Their organizations span health systems, payers, biopharma, and patient advocacy. They shape what comes next.
Interested in being a Founding Member? Sign up by December 31, 2026.
About Signals
A kidney health media and research platform.
Signals Group is a kidney health media and research platform reaching more than 20,000 clinicians, policymakers, and industry leaders across 60+ countries. Our work covers the clinical, commercial, and policy frontiers of kidney and cardiometabolic care.
The membership is the community layer of a broader platform that also includes original research, an advisory practice working with payers and life-science companies, and Bright Frontier Capital, an early-stage fund focused on kidney and cardiometabolic health.
FAQ